Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancers|January 6, 2018
New Interactors of the Truncated EBNA-LP Protein Identified by Mass Spectrometry in P3HR1 Burkitt's Lymphoma CellsSonia Chelouah, Emilie Cochet, Sophie Couvé, et al.
International Journal of Medical Informatics|May 11, 2024
Combining deep neural networks, a rule-based expert system and targeted manual coding for ICD-10 coding causes of death of French death certificates from 2018 to 2019Elisa Zambetta, Nirintsoa Razakamanana, Aude Robert, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 2019
Non-linearity and gaps in results distribution over successive Roche Lipase method applications: improvement but persistenceMarie-Aude Robert de Rancher, Camille Gobeaux-Chenevier, Hervé Lemarechal, et al.
European Journal of Medicinal Chemistry|February 18, 2018
Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin AAlma Abou Samra, Aude Robert, Crystal Gov, et al.
Communications Biology|May 15, 2024
Impairing hydrolase transport machinery prevents human melanoma metastasisAlice Nordlinger, Justine Del Rio, Shivang Parikh, et al.
CEUR Workshop Proceedings|January 9, 2018
Clinical Information Extraction at the CLEF eHealth Evaluation lab 2016Aurélie Névéol, K Bretonnel Cohen, Cyril Grouin, et al.
International Journal of Pharmaceutics|November 27, 2022
In vitro evaluation of NA1-115-7-loaded nanoemulsions, an MCL-1-specific inhibitor of natural origin, intended to treat B-cell lymphoproliferative disorders after oral administrationLine Séguy, Florian Daressy, Sophia Lahlil, et al.
Plos One|December 20, 2012
Tubulin tyrosine ligase like 12, a TTLL family member with SET- and TTL-like domains and roles in histone and tubulin modifications and mitosisJan Brants, Kostyantyn Semenchenko, Christine Wasylyk, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2022
NA1-115-7, from Zygogynum pancheri, is a new selective MCL-1 inhibitor inducing the apoptosis of hematological cancer cells but non-toxic to normal blood cells or cardiomyocytesFlorian Daressy, Line Séguy, Loëtitia Favre, et al.
Cancers|October 29, 2025
RNA-seq Splicing Profile of the CDH1 Gene and Its Impact on the Clinical Pathogenicity Classification of CDH1 Variants: A Description of Alternative and Pathogenic Splicing PatternsMolka Sebai, Roseline Tang, Yahia Adnani, et al.
Pageof 3